Our results showed that inhibition of p53 led to increased survival of both tumor lines treated with GTE, especially MCF-7, where an almost 50% increase in the viability could be observed on cells treated with 250 μg/mL of GTE (Figure 4F and Figure 5F). This evidence concerns the gene TP53 and neoplasm.